Ralph Alcendor PhD
Email Randy
2001-2007 Ph.D. Student, UMDNJ
1996-2000 BS University of Virgin Islands, USA
Former Lab Members
Soichiro Usui MD PhD
Email Soichiro
2005-2008 Postdoctoral Fellow, UMDNJ
2000-2005 Ph.D., Kanazawa University, Japan
1997-2005 Clinical Fellow, Kanazawa University, Japan
Research Interests: MST1, cardiac apoptosis
Tetsuro Ago MD PhD
Email Tetsuro
2005-2008 Postdoctoral Fellow, UMDNJ
1987-1993 M.D., Kyushu University School of Medicine, Japan
Research Interests: Thioredoxin, Histone Modification, Reactive Oxygen Species
Takahisa Matsuda PhD
Email Taka
2005-2008 Postdoctral Fellow, UMDNJ
2002-2005 PhD, Osaka University, Osaka, Japan
2000-2002 MS, Osaka University, Japan
1996-2000 BS, Osaka University, Japan
Research Interests: Mst1, GSK-3
Noritsugu Nakano MD PhD
Email Nori
2006-2008 Postdoctral Fellow, UMDNJ
Shiori Kyoi MD PhD
Email Shiori
2006-2008 Postdoctoral Fellow, UMDNJ, NJ, USA
2001-2006 M.D., Kansai Medical University, Japan
1997-2006 Clinical Fellow, Cardiovascular Center, Kansai Medical University,Osaka, Japan
Research Interest: MST1, Beclin1, Apoptosis, Autophagy
Hsu Chiao-Po MD PhD
Email Chiao-Po
2006-2008 Postdoctoral Fellow, UMDNJ, NJ, USA
1985-1992 MD Natinal Yang-Ming University,Taiwan
Research Interests: Nampt, Sirt1
Jonathan Galeotti BS
2001-2009 Research Teaching Specialist IV
Junya Kuroda MD PhD
Email Junya
2008-2010 Postdoctoral fellow, UMDNJ
1999-2003 Ph.D., Kyushu University, Japan
1990-1996 M.D., Kyushu University, Japan
Research Interests: NAD(P)H oxidase
Nirmala Hariharan PhD
Email Nirmala
2007 -2010 Ph.D Student: Department of Cell Biology and Molecular Medicine
2005-Present CBMM PhD student, UMDNJ
2000-2005 B.E Birla Institute of Technology & Science, Pilani, India
Thesis Topic: Role of FOXO transcription factors in the heart.
Jaeyeaon Cho PhD
Email Jaeyeaon
2010- 2011 Postdoctral Fellow, UMDNJ
2004 -2010 Ph.D Student, Biomedical Science Program, UMDNJ
2001- 2004 MS New Jersey Institute of Technology, Newark, NJ, USA
1995- 1999 BS Inha University, Korea
Thesis: GSK-3-beta mediates cardiomyocyte differentiation of bone marrow derived
mesenchymal stem cells and improves cell therapy effects after myocardial infraction.
Research Interests: Cardiomyocyte differentiation and stem cell therapy for myocardial
infarction.